NASDAQ
Oramed Pharmaceuticals Inc. (ORMP)
♥ 370 Thanks from members
Oramed Pharmaceuticals Inc. (ORMP) experiences choppy trading near crucial support levels between $3.71 and $4.12, counterbalanced by a $20 million equity buyback announcement and optimistic AI price targets averaging $4.76.